Lung problems in connective tissue diseases
Part of Skin clinical trials.
This study looks at people with connective tissue diseases who also have lung problems. It helps doctors understand and manage these lung issues better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a connective tissue disease (such as lupus, scleroderma, or rheumatoid arthritis).
- You have lung-related symptoms like cough, shortness of breath, or chest pain.
- Your lung problems have been linked to your connective tissue disease, not another cause.
- Your doctor can see changes in your lungs on imaging tests (like X-ray or CT).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people aged 18 and older who have a connective tissue disease and lung involvement. It aims to better understand how these lung problems progress and may help doctors choose better care.
This trial is studying people who have both a connective tissue disease (like lupus or scleroderma) and pulmonary hypertension, which is high blood pressure in the lungs. By participating, doctors can learn more about how to better treat this combination.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This trial is a registry that collects health information from people with certain types of pulmonary hypertension linked to connective tissue diseases. It helps doctors understand patterns of disease and outcomes, which can guide future care and studies.
This study follows people who are being seen for lung scarring (also called ILD) and compares them with family members without lung scarring. It helps researchers better understand how this condition changes over time and what to look for in the future.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
Hear when a new Connective Tissue Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.